Integra LifeSciences Holdings Corporation Launches Portfolio of Advanced Orthobiologics for Spine Surgery

PLAINSBORO, N.J., March 9, 2010 (GLOBE NEWSWIRE) -- Integra Lifesciences Holdings Corporation (Nasdaq:IART) announced today that it has created a portfolio of advanced bone grafting products, which will be sold in conjunction with its Integra Spine implants, providing spine surgeons a comprehensive set of solutions for spine fusion.

MORE ON THIS TOPIC